Two retrospective studies, conducted among patients affected by NSCLC, reported that baseline steroids administration was associated with a lower Objective Response Rate (ORR) and a worse PFS and OS with anti-PD-1/PD-L1 treatment [9,21,31]. Here, CD274 is linked to non-small cell lung carcinoma.